Press release
Melanoma Treatment Market expected to reach $5.64 billion by 2023 with 15.5% CAGR, Says MarketIntelReports
“Melanoma Global Clinical Trials Review, H1, 2016" provides an overview of Melanoma clinical trials scenario. This report provides top line data relating to the clinical trials on Melanoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe.
Browse Melanoma Global Clinical Trials Review, H1, 2016 Research Report
http://www.marketintelreports.com/report/gdhc3214ctidb/melanoma-global-clinical-trials-review-h1-2016
MarketIntelReports latest report states that this impressive growth, which will occur across the eight major markets (8MM) of the US, France, Germany, Italy, Spain, UK, Japan, and Australia, will be driven primarily by increasing sales of Bristol-Myers Squibb's blockbuster immunotherapy Yervoy.
"While Yervoy's sales will be negatively impacted by the first-line uptake of PD-1-targeting monoclonal antibodies (mAbs) Keytruda and Opdivo from 2015 to 2017, the approval of the Yervoy/Opdivo combination will recover the former's market position in the second half of the forecast period.
"Furthermore, Yervoy's label expansion into the lucrative adjuvant setting will further enhance its sales from 2019 onwards."
MarketIntelReports estimates sales of $889 million for Yervoy in the 8MM in 2013, and forecasts this to rise at a CAGR of 8.2% to $1.96 billion by 2023.
Some of the prominent players of market:
Bristol-Myers Squibb Company F. Hoffmann-La Roche Ltd. GlaxoSmithKline Plc Merck & Co., Inc. Novartis AG AstraZeneca Plc Pfizer Inc. Ludwig Institute For Cancer Research Ltd Eisai Co., Ltd. Amgen Inc. and Others
The BRAF/MEK inhibitor combinations, in particular Novartis' Tafinlar/Mekinist and Roche/Exelixis' Zelboraf/cobimetinib, will replace standard BRAF inhibitor monotherapy of Zelboraf or Tafinlar. In addition, Keytruda and Opdivo will garner rapid growth in both BRAF mutated and wild-type settings.
"These novel agents and combinations will experience large uptake globally, thanks to their improved overall response rate and overall survival, along with their manageable side effect profiles. Notably, the combination treatments will fetch a higher premium price than monotherapies, which, on top of raising company sales, will also result in greater pushback from payers."
MarketIntelReports expects these new, more efficacious entrants to replace generic chemotherapy-only regimens in the first- and second-line settings, therefore driving the growth of the overall melanoma market and extending the lines of treatment available for patients.
"The launch of these improved agents will ensure that many patients receive one to two lines of treatment with branded premium-priced drugs by 2023 and beyond."
Request for Sample Brochure of Report @ http://www.marketintelreports.com/pdfdownload.php?id=gdhc3214ctidb
MarketIntelReports expects these new, more efficacious entrants to replace generic chemotherapy-only
About us:
MarketIntelReports (MIR) aim to empower our clients to successfully manage and outperform in their business decisions, we do this by providing Premium Market Intelligence, Strategic Insights and Databases from a range of Global Publishers.
A group of industry veterans who are well experienced in reputed international consulting firms after identifying the sourcing needs of MNCs for market intelligence, have together started this business savior MarketIntelReports.
Contact us:
Sales Manager
Mayur S.
2711 Centerville Road, Suite 400, Wilmington,Delaware,19808
United States
www.marketintelreports.com
sales@marketintelreports.com
Telephone: 1-302-261-5343
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Melanoma Treatment Market expected to reach $5.64 billion by 2023 with 15.5% CAGR, Says MarketIntelReports here
News-ID: 350984 • Views: …
More Releases from MarketIntelReports
Study on Future Growth Drivers of the Cloud Integration Market
Cloud Integration or integration platform as a service (iPaaS) is one of the fast emerging forms of cloud computing services that are delivered to configure data with various application programs. These application programs range from enterprise risk management (ERM), customer relationship management (CRM), database management system (DBMS), and business process management to web conferencing, and emails, etc. Cloud integration services are especially designed to help organizations of all sizes to…
Analysis of Variables Pushing the Expansion of the Workforce Management Market
Workforce Management is an integrated set of processes that an institution or organization uses to optimize the productivity of its employees on the individual, departmental, and entity-wide levels.
This report identifies the Workforce Management market size in terms of value for the year 2014-2016, and forecast of the same for year 2021. It highlights potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges,…
Study on Future Growth Drivers of the Blockchain Market
The blockchain technology market size is estimated to grow from USD 210.2 Million in 2016 to USD 2,312.5 Million by 2021, at a Compound Annual Growth Rate (CAGR) of 61.5% during the forecast period. In the report, 2015 is considered the base year, while the forecast period is 2016–2021.
The objective of the report is to define, describe, and forecast the blockchain technology market on the basis of providers, applications, deployment…
Glass Bonding Adhesives Market by End-Use Industry (Furniture, Electronics, Medi …
The use of adhesives and glues as a bonding agent between glass and other materials is increasing now a days. The glass bonding adhesives has a wide range of applications in automotive industry for bonding the glass in vehicles, manufacturing of water tanks and optical glasses, bonding of window glass to frame or structure etc. The selection of a suitable adhesive for proper bonding of glass depends upon various factors…
More Releases for Melanoma
Global Melanoma Drugs Market Insights, Forecast
Melanoma is the type of cancer, in which the normal melanin-producing cells called melanocytes are turned into cancerous cells. Melanoma is usually, but not always cancer of the skin and is the most dangerous type of cancer. Mutation in melanin-producing melanocytes leads to uncontrolled division of cells forming the malignant tumor. Mainly there are three general categories of melanoma as Cutaneous, mucosal and ocular. Cutaneous melanoma is melanoma of the…
Global Drugs for Melanoma Market Insights, Forecast
Melanoma is the type of cancer, in which the normal melanin-producing cells called melanocytes are turned into cancerous cells. Melanoma is usually, but not always cancer of the skin and is the most dangerous type of cancer. Mutation in melanin-producing melanocytes leads to uncontrolled division of cells forming the malignant tumor. Mainly there are three general categories of melanoma as Cutaneous, mucosal and ocular. Cutaneous melanoma is melanoma of the…
Intraocular Melanoma Treatment Market Drivers
Neurological disorder diagnostics tools are medical devices, which are used in diagnosis of various neurological disorders such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and Multiple Sclerosis. The devices which are majorly used in diagnosis are imaging tools such as Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and in-vitro diagnostics tools such as biomarker and biopsy. Increasing prevalence of neurological disorders in the recent past has increased demand for diagnostic…
Europe and Israel Mobile Applications for Melanoma Detection Market: Rising prev …
According to the TMR report, the Europe mobile applications for melanoma detection market could collect a larger revenue of around US$1.5 mn by the end of 2022. Even though Greece is dealing with economic volatility, it has been prognosticated to exhibit a perpetually elevating growth until the same year.
Rise in Mortality Rate and Melanoma Incidence Puts Heavy Influence on Early Diagnosis
Europe and Israel mobile applications for melanoma detection market has…
Melanoma Treatment Market – Global Industry Insights, 2025
Melanoma is a type of skin cancer that develops from the pigment cells known as melanocytes. It is caused due to high exposure to ultraviolet rays, which leads to sunburn, especially at high altitudes. Melanoma is categorized into three: cutaneous, mucosal, and ocular. Cutaneous affects the skin, mucosal affects the mucous membrane in the mouth and nasal passage, and ocular affects the eye. However, early detection of melanoma helps in…
Malignant Melanoma Drug Market Malignant Melanoma Clinical Pipeline Report
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Malignant Melanoma
2. Malignant Melanoma Drug Mechanism of Action
3. Global Malignant Melanoma Market Analysis
3.1 Current Market Scenario
3.2 Global Malignant Melanoma Pipeline Overview
4. Global Malignant Melanoma Drug Market Dynamics
4.1 Favorable Market Parameters
4.2 Commercialization Challenges
5. Global Malignant Melanoma Drug Market Future Prospects
6. Global Malignant Melanoma Clinical Pipeline By…
